{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:26:35Z","timestamp":1760865995219,"version":"3.37.3"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153816","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T14:06:58Z","timestamp":1461247618000},"page":"e0153816","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research"],"prefix":"10.1371","volume":"11","author":[{"given":"Hye Won","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Ryul","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyong-Hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Joo","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Ryung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So-Young","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Soon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hee","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Yang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Nam","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Cheol","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Geun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon-Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8029-7355","authenticated-orcid":true,"given":"Yong-Gil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Korean Society of Spondyloarthritis Research","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/ijd.12628","article-title":"The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents","volume":"54","author":"T Ergun","year":"2015","journal-title":"Int J Dermatol"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jbspin.2010.12.004","article-title":"Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review","volume":"78","author":"L Baronnet","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/cid\/cit489","article-title":"Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-alpha inhibitors: systematic review of the literature","volume":"57","author":"SS Toussi","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"21","key":"ref4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2011.1692","article-title":"Initiation of tumor necrosis factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases","volume":"306","author":"CG Grijalva","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","year":"2005","journal-title":"Thorax"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","article-title":"Tumour necrosis factor antagonists: structure, function, and tuberculosis risks","volume":"8","author":"RS Wallis","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"ref7","first-page":"679","article-title":"Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong\u2014the role of TNF blockers in an area of high tuberculosis burden","volume":"28","author":"LS Tam","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s10067-013-2387-z","article-title":"Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area","volume":"33","author":"HW Kim","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/1756-185X.12530","article-title":"Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden","volume":"18","author":"SM Jung","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"I Solovic","year":"2010","journal-title":"Eur Respir J"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","article-title":"French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers","volume":"62","author":"X Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14728214.2015.993378","article-title":"Emerging drugs for the treatment of axial and peripheral spondyloarthritis","volume":"20","author":"J Braun","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/rheumatology\/kes026","article-title":"Update of the literature review on treatment with biologics as a basis for the first update of the ASAS\/EULAR management recommendations of ankylosing spondylitis","volume":"51","author":"X Baraliakos","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"ref14","first-page":"CD005468","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","volume":"4","author":"LJ Maxwell","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"R439","DOI":"10.1186\/ar1693","article-title":"Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab","volume":"7","author":"X Baraliakos","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","article-title":"Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab","volume":"43","author":"J Brandt","year":"2000","journal-title":"Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3899\/jrheum.140106","article-title":"Restarting biologics and management of patients with flares of inflammatory rheumatic disorders or psoriasis during active tuberculosis treatment","volume":"91","author":"F Cantini","year":"2014","journal-title":"J Rheumatol Suppl"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"S van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"unstructured":"Joint Committee for the Revision of Korean Guidelines for Tuberculosis KCfDCaP. Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korean Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 2nd ed. Seoul and Cheongwon. 2014.","key":"ref19"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/rheumatology\/keu041","article-title":"Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors","volume":"53","author":"YJ Kim","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3346\/jkms.2014.29.1.38","article-title":"Safe re-administration of tumor necrosis factor-alpha (TNFalpha) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFalpha therapy","volume":"29","author":"YS Suh","year":"2014","journal-title":"J Korean Med Sci"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1469-0691.2007.01891.x","article-title":"Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment","volume":"14","author":"B Denis","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"15","key":"ref23","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"J Keane","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/j.crohns.2013.03.004","article-title":"Tuberculosis in anti-TNF-alpha treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population","volume":"7","author":"C Abreu","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20040646","article-title":"Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice","volume":"200","author":"PC Karakousis","year":"2004","journal-title":"J Exp Med"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/598504","article-title":"Adalimumab treatment of life-threatening tuberculosis","volume":"48","author":"RS Wallis","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1759720X12468658","article-title":"Axial spondyloarthritis: is there a treatment of choice?","volume":"5","author":"D Poddubnyy","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"JJ Gomez-Reino","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"L Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jinf.2014.02.019","article-title":"A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients","volume":"69","author":"YM Lee","year":"2014","journal-title":"J Infect"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijid.2014.11.028","article-title":"Understanding anti-tuberculosis drug efficacy: rethinking bacterial populations and how we model them","volume":"32","author":"D Evangelopoulos","year":"2015","journal-title":"Int J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:43:12Z","timestamp":1540255392000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153816"}},"subtitle":[],"editor":[{"given":"James T.","family":"Rosenbaum","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153816","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}